| Entry |
|
|---|
| Name |
HBV HBeAg to TLR2/4-NFKB signaling pathway
|
|---|
| Definition |
C -| NFKB |
|---|
| Expanded |
K23129 -| (4790+5970) |
|---|
| Class |
|
|---|
| Type |
Pathogen
|
|---|
| Pathway |
|
|---|
| Disease |
| H00048 | Hepatocellular carcinoma |
|
|---|
| Gene |
| 4790 | NFKB1; nuclear factor kappa B subunit 1 |
| 5970 | RELA; RELA proto-oncogene, NF-kB subunit |
|
|---|
| Perturbant |
| K23129 (C) | C; HBV capsid protein |
|
|---|
| Reference |
|
|---|
| Authors |
Bagheri V, Askari A, Arababadi MK, Kennedy D |
|---|
| Title |
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection? |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A |
|---|
| Title |
The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
